APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dermatology Drug

A dermatology drug is a medication used to prevent, diagnose, manage, and treat skin diseases and conditions. Skin diseases can include, but are not limited to, acne, psoriasis, eczema, dermatitis, fungal infections, viral infections (such as herpes zoster), and other skin abnormalities.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A dermatology drug is a medication used to prevent, diagnose, manage, and treat skin diseases and conditions. Skin diseases can include, but are not limited to, acne, psoriasis, eczema, dermatitis, fungal infections, viral infections (such as herpes zoster), and other skin abnormalities. These medications can be prescription or over-the-counter and can be administered in various forms such as oral, topical (creams, gels, ointments), and injectable.

Common types of dermatology drugs include:

a. Antibiotics: Used to treat bacterial infections, such as acne and cellulitis.

b. Antifungal agents: Used to treat fungal infections, such as ringworm and candidiasis.

c. Antiviral medications: Used to treat viral infections, such as shingles and warts.

d. Steroids: Used to reduce inflammation and allergic reactions, commonly used for eczema and psoriasis.

e. Immunomodulators: Used to modulate the immune system, such as tacrolimus and pimecrolimus.

f. Vitamin D analogs: Used to treat psoriasis, such as calcipotriene.

g. Keratolytics: Used to treat acne by promoting exfoliation, such as benzoyl peroxide and retinoids.

The research object may be an ingredient, device, preparation or care service. These supply stages have different specifications and measurement units; an ingredient identity or device name does not establish a clinical outcome.

What turns activity into demand

Qualified use at the specified treatment or instrument boundary creates purchases through protocol, utilisation and replacement. A product, clinical service and complete care episode measure different supplied objects.

The commercial boundary

For Dermatology Drug, distinguish the supplied product from its inputs and the complete application. Report types and applications may overlap; retain the selected edition's product definition, geography, period, unit and transaction basis when comparing estimates.

Which conditions determine usable dermatology drug performance?

A dermatology drug is a medication used to prevent, diagnose, manage, and treat skin diseases and conditions. Skin diseases can include, but are not limited to, acne, psoriasis, eczema, dermatitis, fungal infections, viral infections (such as herpes zoster), and other skin abnormalities. Confirm the specified composition or device function, intended use and supplied unit. Separate ingredients, finished preparations, equipment and treatment activity before comparing quantities or revenue; use the report scope rather than inferring efficacy from an illustration.

Selected research

Industry Growth & Trends

Global Dermatology Drug Industry Growth and Trends Forecast to 2032

21 December 2025121 pages

Choose your research edition.

Industry ResearchDermatology Drug Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Dermatology Drug Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Dermatology Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dermatology Drug Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Dermatology Drug Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

A dermatology drug is a medication used to prevent, diagnose, manage, and treat skin diseases and conditions. Skin diseases can include, but are not limited to, acne, psoriasis, eczema, dermatitis, fungal infections, viral infections (such as herpes zoster), and other skin abnormalities. These medications can be prescription or over-the-counter and can be administered in various forms such as oral, topical (creams, gels, ointments), and injectable.

Common types of dermatology drugs include:

a. Antibiotics: Used to treat bacterial infections, such as acne and cellulitis.

Read the full market overview

b. Antifungal agents: Used to treat fungal infections, such as ringworm and candidiasis.

c. Antiviral medications: Used to treat viral infections, such as shingles and warts.

d. Steroids: Used to reduce inflammation and allergic reactions, commonly used for eczema and psoriasis.

e. Immunomodulators: Used to modulate the immune system, such as tacrolimus and pimecrolimus.

f. Vitamin D analogs: Used to treat psoriasis, such as calcipotriene.

g. Keratolytics: Used to treat acne by promoting exfoliation, such as benzoyl peroxide and retinoids.

According to APO Research, the global Dermatology Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Dermatology Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Dermatology Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

The Asia Pacific market for Dermatology Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Dermatology Drug market include AbbVie, Johnson & Johnson, Bayer, Galderma, Bristol-Myers Squibb, Novartis, Pfizer, Merz Pharma and Valeant, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Dermatology Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Dermatology Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dermatology Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dermatology Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Dermatology Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Dermatology Drug Market by Company

AbbVie

Johnson & Johnson

Bayer

Galderma

Bristol-Myers Squibb

Novartis

Pfizer

Merz Pharma

Valeant

Leo Pharma A/S

GlaxoSmithKline (GSK)

Allergan

Almirall S.A.

Amgen

Astellas

Concert Pharmaceuticals

Eli Lilly and Company

Lupin

Mayne Pharma

Merck KGaA

AstraZeneca plc

Roivant Sciences (Dermavant Sciences)

Dermatology Drug Segment by Type

External Use

Oral

Injection

Dermatology Drug Segment by Application

Psoriasis

Skin Infections

Acne

Dermatitis

Others

Dermatology Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dermatology Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dermatology Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dermatology Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Dermatology Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Dermatology Drug Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Dermatology Drug Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Dermatology Drug Market Share by Region (2021-2026) Table 4. Global Dermatology Drug Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Dermatology Drug Market Share by Region (2027-2032) Table 6. Global Dermatology Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Dermatology Drug Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Dermatology Drug Market Size Share by Type (2021-2026) Table 9. Global Dermatology Drug Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Dermatology Drug Market Size Share Forecasted by Type (2027-2032) Table 11. North America Dermatology Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Dermatology Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Dermatology Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Dermatology Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Dermatology Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Dermatology Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Dermatology Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Dermatology Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Dermatology Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Dermatology Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Dermatology Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Dermatology Drug Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Dermatology Drug Market Size Share by Application (2021-2026) Table 24. Global Dermatology Drug Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Dermatology Drug Market Size Share Forecasted by Application (2027-2032) Table 26. North America Dermatology Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Dermatology Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Dermatology Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Dermatology Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Dermatology Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Dermatology Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Dermatology Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Dermatology Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Dermatology Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Dermatology Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Dermatology Drug Industry Trends Table 37. Dermatology Drug Industry Drivers Table 38. Dermatology Drug Industry Opportunities and Challenges Table 39. Dermatology Drug Industry Restraints Table 40. Global Dermatology Drug Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Dermatology Drug Revenue Market Share by Company (2021-2026) Table 42. Global Dermatology Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Dermatology Drug Key Company Headquarters & Area Served Table 44. Global Dermatology Drug Company, Product Type & Application Table 45. Global Dermatology Drug Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Dermatology Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. AbbVie Company Information Table 49. AbbVie Business Overview Table 50. AbbVie Dermatology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. AbbVie Dermatology Drug Product Portfolio Table 52. AbbVie Recent Development Table 53. Johnson & Johnson Company Information Table 54. Johnson & Johnson Business Overview Table 55. Johnson & Johnson Dermatology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Johnson & Johnson Dermatology Drug Product Portfolio Table 57. Johnson & Johnson Recent Development Table 58. Bayer Company Information Table 59. Bayer Business Overview Table 60. Bayer Dermatology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Bayer Dermatology Drug Product Portfolio Table 62. Bayer Recent Development Table 63. Galderma Company Information Table 64. Galderma Business Overview Table 65. Galderma Dermatology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Galderma Dermatology Drug Product Portfolio Table 67. Galderma Recent Development Table 68. Bristol-Myers Squibb Company Information Table 69. Bristol-Myers Squibb Business Overview Table 70. Bristol-Myers Squibb Dermatology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Bristol-Myers Squibb Dermatology Drug Product Portfolio Table 72. Bristol-Myers Squibb Recent Development Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Dermatology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Novartis Dermatology Drug Product Portfolio Table 77. Novartis Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Dermatology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Pfizer Dermatology Drug Product Portfolio Table 82. Pfizer Recent Development Table 83. Merz Pharma Company Information Table 84. Merz Pharma Business Overview Table 85. Merz Pharma Dermatology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Merz Pharma Dermatology Drug Product Portfolio Table 87. Merz Pharma Recent Development Table 88. Valeant Company Information Table 89. Valeant Business Overview Table 90. Valeant Dermatology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Valeant Dermatology Drug Product Portfolio Table 92. Valeant Recent Development Table 93. Leo Pharma A/S Company Information Table 94. Leo Pharma A/S Business Overview Table 95. Leo Pharma A/S Dermatology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Leo Pharma A/S Dermatology Drug Product Portfolio Table 97. Leo Pharma A/S Recent Development Table 98. GlaxoSmithKline (GSK) Company Information Table 99. GlaxoSmithKline (GSK) Business Overview Table 100. GlaxoSmithKline (GSK) Dermatology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. GlaxoSmithKline (GSK) Dermatology Drug Product Portfolio Table 102. GlaxoSmithKline (GSK) Recent Development Table 103. Allergan Company Information Table 104. Allergan Business Overview Table 105. Allergan Dermatology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Allergan Dermatology Drug Product Portfolio Table 107. Allergan Recent Development Table 108. Almirall S.A. Company Information Table 109. Almirall S.A. Business Overview Table 110. Almirall S.A. Dermatology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Almirall S.A. Dermatology Drug Product Portfolio Table 112. Almirall S.A. Recent Development Table 113. Amgen Company Information Table 114. Amgen Business Overview Table 115. Amgen Dermatology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Amgen Dermatology Drug Product Portfolio Table 117. Amgen Recent Development Table 118. Astellas Company Information Table 119. Astellas Business Overview Table 120. Astellas Dermatology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Astellas Dermatology Drug Product Portfolio Table 122. Astellas Recent Development Table 123. Concert Pharmaceuticals Company Information Table 124. Concert Pharmaceuticals Business Overview Table 125. Concert Pharmaceuticals Dermatology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Concert Pharmaceuticals Dermatology Drug Product Portfolio Table 127. Concert Pharmaceuticals Recent Development Table 128. Eli Lilly and Company Company Information Table 129. Eli Lilly and Company Business Overview Table 130. Eli Lilly and Company Dermatology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Eli Lilly and Company Dermatology Drug Product Portfolio Table 132. Eli Lilly and Company Recent Development Table 133. Lupin Company Information Table 134. Lupin Business Overview Table 135. Lupin Dermatology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Lupin Dermatology Drug Product Portfolio Table 137. Lupin Recent Development Table 138. Mayne Pharma Company Information Table 139. Mayne Pharma Business Overview Table 140. Mayne Pharma Dermatology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Mayne Pharma Dermatology Drug Product Portfolio Table 142. Mayne Pharma Recent Development Table 143. Merck KGaA Company Information Table 144. Merck KGaA Business Overview Table 145. Merck KGaA Dermatology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Merck KGaA Dermatology Drug Product Portfolio Table 147. Merck KGaA Recent Development Table 148. AstraZeneca plc Company Information Table 149. AstraZeneca plc Business Overview Table 150. AstraZeneca plc Dermatology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. AstraZeneca plc Dermatology Drug Product Portfolio Table 152. AstraZeneca plc Recent Development Table 153. Roivant Sciences (Dermavant Sciences) Company Information Table 154. Roivant Sciences (Dermavant Sciences) Business Overview Table 155. Roivant Sciences (Dermavant Sciences) Dermatology Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Roivant Sciences (Dermavant Sciences) Dermatology Drug Product Portfolio Table 157. Roivant Sciences (Dermavant Sciences) Recent Development Table 158. North America Dermatology Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. North America Dermatology Drug Market Size by Country (2021-2026) & (US$ Million) Table 160. North America Dermatology Drug Market Share by Country (2021-2026) Table 161. North America Dermatology Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. North America Dermatology Drug Market Share Forecast by Country (2027-2032) Table 163. Europe Dermatology Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Europe Dermatology Drug Market Size by Country (2021-2026) & (US$ Million) Table 165. Europe Dermatology Drug Market Share by Country (2021-2026) Table 166. Europe Dermatology Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Europe Dermatology Drug Market Share Forecast by Country (2027-2032) Table 168. Asia-Pacific Dermatology Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Asia-Pacific Dermatology Drug Market Size by Country (2021-2026) & (US$ Million) Table 170. Asia-Pacific Dermatology Drug Market Share by Country (2021-2026) Table 171. Asia-Pacific Dermatology Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Asia-Pacific Dermatology Drug Market Share Forecast by Country (2027-2032) Table 173. Latin America Dermatology Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Latin America Dermatology Drug Market Size by Country (2021-2026) & (US$ Million) Table 175. Latin America Dermatology Drug Market Share by Country (2021-2026) Table 176. Latin America Dermatology Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Latin America Dermatology Drug Market Share Forecast by Country (2027-2032) Table 178. Middle East & Africa Dermatology Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East & Africa Dermatology Drug Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East & Africa Dermatology Drug Market Share by Country (2021-2026) Table 181. Middle East & Africa Dermatology Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East & Africa Dermatology Drug Market Share Forecast by Country (2027-2032) Table 183. Research Programs/Design for This Report Table 184. Authors List of This Report Table 185. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Dermatology Drug Product Image Figure 3. Global Dermatology Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Dermatology Drug Market Size (2021-2032) & (US$ Million) Figure 5. Global Dermatology Drug Market Share by Region: 2025 VS 2032 Figure 6. Global Dermatology Drug Market Share by Region (2021-2032) Figure 7. North America Dermatology Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Dermatology Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Dermatology Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Dermatology Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Dermatology Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. External Use Image Figure 13. Global External Use Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Oral Image Figure 15. Global Oral Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Injection Image Figure 17. Global Injection Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Dermatology Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Dermatology Drug Market Share by Type 2025 VS 2032 Figure 20. North America Dermatology Drug Market Size Share by Type (2021-2032) Figure 21. Europe Dermatology Drug Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Dermatology Drug Market Size Share by Type (2021-2032) Figure 23. Latin America Dermatology Drug Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Dermatology Drug Market Size Share by Type (2021-2032) Figure 25. Psoriasis Image Figure 26. Global Psoriasis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Skin Infections Image Figure 28. Global Skin Infections Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Acne Image Figure 30. Global Acne Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Dermatitis Image Figure 32. Global Dermatitis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Dermatology Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Dermatology Drug Market Share by Application 2025 VS 2032 Figure 37. North America Dermatology Drug Market Size Share by Application (2021-2032) Figure 38. Europe Dermatology Drug Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Dermatology Drug Market Size Share by Application (2021-2032) Figure 40. Latin America Dermatology Drug Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Dermatology Drug Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Dermatology Drug Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Dermatology Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Dermatology Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Dermatology Drug Market Share by Country (2021-2032) Figure 47. Europe Dermatology Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Dermatology Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Dermatology Drug Market Share by Country (2021-2032) Figure 50. Asia-Pacific Dermatology Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Dermatology Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Dermatology Drug Market Share by Country (2021-2032) Figure 53. Latin America Dermatology Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Dermatology Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Dermatology Drug Market Share by Country (2021-2032) Figure 56. Middle East & Africa Dermatology Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Dermatology Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Dermatology Drug Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • External Use
  • Oral
  • Injection
Applications
  • Psoriasis
  • Skin Infections
  • Acne
  • Dermatitis
  • Others
Companies covered
  • AbbVie
  • Johnson & Johnson
  • Bayer
  • Galderma
  • Bristol-Myers Squibb
  • Novartis
  • Pfizer
  • Merz Pharma
  • Valeant
  • Leo Pharma A/S
  • GlaxoSmithKline (GSK)
  • Allergan
  • Almirall S.A.
  • Amgen
  • Astellas
  • Concert Pharmaceuticals
  • Eli Lilly and Company
  • Lupin
  • Mayne Pharma
  • Merck KGaA
  • AstraZeneca plc
  • Roivant Sciences (Dermavant Sciences)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Dermatology Drug Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Dermatology Drug Market Size by Region (2021-2032)
  5. 1.4.1 Global Dermatology Drug Market Size by Region (2021-2026)
  6. 1.4.2 Global Dermatology Drug Market Size by Region (2027-2032)
  7. 1.5 Key Regions Dermatology Drug Market Size (2021-2032)
  8. 1.5.1 North America Dermatology Drug Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Dermatology Drug Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Dermatology Drug Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Dermatology Drug Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Dermatology Drug Market Size Growth Rate (2021-2032)
2 Dermatology Drug Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 External Use
  3. 2.1.2 Oral
  4. 2.1.3 Injection
  5. 2.2 Global Dermatology Drug Market Size by Type
  6. 2.2.1 Global Dermatology Drug Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Dermatology Drug Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Dermatology Drug Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Dermatology Drug Market Size by Regions
  10. 2.3.1 North America Dermatology Drug Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Dermatology Drug Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Dermatology Drug Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Dermatology Drug Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Dermatology Drug Market Size Breakdown by Type (2021-2026)
3 Dermatology Drug Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Psoriasis
  3. 3.1.2 Skin Infections
  4. 3.1.3 Acne
  5. 3.1.4 Dermatitis
  6. 3.1.5 Others
  7. 3.2 Global Dermatology Drug Market Size by Application
  8. 3.2.1 Global Dermatology Drug Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Dermatology Drug Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Dermatology Drug Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Dermatology Drug Market Size by Regions
  12. 3.3.1 North America Dermatology Drug Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Dermatology Drug Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Dermatology Drug Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Dermatology Drug Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Dermatology Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Dermatology Drug Industry Trends
  2. 4.2 Dermatology Drug Industry Drivers
  3. 4.3 Dermatology Drug Industry Opportunities and Challenges
  4. 4.4 Dermatology Drug Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Dermatology Drug Revenue (2021-2026)
  2. 5.2 Global Dermatology Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Dermatology Drug Key Company Headquarters & Area Served
  4. 5.4 Global Dermatology Drug Company, Product Type & Application
  5. 5.5 Global Dermatology Drug Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Dermatology Drug Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Dermatology Drug Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Dermatology Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 AbbVie
  2. 6.1.1 AbbVie Company Information
  3. 6.1.2 AbbVie Business Overview
  4. 6.1.3 AbbVie Dermatology Drug Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 AbbVie Dermatology Drug Product Portfolio
  6. 6.1.5 AbbVie Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Dermatology Drug Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Dermatology Drug Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Bayer
  14. 6.3.1 Bayer Company Information
  15. 6.3.2 Bayer Business Overview
  16. 6.3.3 Bayer Dermatology Drug Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Bayer Dermatology Drug Product Portfolio
  18. 6.3.5 Bayer Recent Developments
  19. 6.4 Galderma
  20. 6.4.1 Galderma Company Information
  21. 6.4.2 Galderma Business Overview
  22. 6.4.3 Galderma Dermatology Drug Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Galderma Dermatology Drug Product Portfolio
  24. 6.4.5 Galderma Recent Developments
  25. 6.5 Bristol-Myers Squibb
  26. 6.5.1 Bristol-Myers Squibb Company Information
  27. 6.5.2 Bristol-Myers Squibb Business Overview
  28. 6.5.3 Bristol-Myers Squibb Dermatology Drug Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Bristol-Myers Squibb Dermatology Drug Product Portfolio
  30. 6.5.5 Bristol-Myers Squibb Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Dermatology Drug Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Novartis Dermatology Drug Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Dermatology Drug Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Dermatology Drug Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 Merz Pharma
  44. 6.8.1 Merz Pharma Company Information
  45. 6.8.2 Merz Pharma Business Overview
  46. 6.8.3 Merz Pharma Dermatology Drug Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Merz Pharma Dermatology Drug Product Portfolio
  48. 6.8.5 Merz Pharma Recent Developments
  49. 6.9 Valeant
  50. 6.9.1 Valeant Company Information
  51. 6.9.2 Valeant Business Overview
  52. 6.9.3 Valeant Dermatology Drug Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Valeant Dermatology Drug Product Portfolio
  54. 6.9.5 Valeant Recent Developments
  55. 6.10 Leo Pharma A/S
  56. 6.10.1 Leo Pharma A/S Company Information
  57. 6.10.2 Leo Pharma A/S Business Overview
  58. 6.10.3 Leo Pharma A/S Dermatology Drug Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Leo Pharma A/S Dermatology Drug Product Portfolio
  60. 6.10.5 Leo Pharma A/S Recent Developments
  61. 6.11 GlaxoSmithKline (GSK)
  62. 6.11.1 GlaxoSmithKline (GSK) Company Information
  63. 6.11.2 GlaxoSmithKline (GSK) Business Overview
  64. 6.11.3 GlaxoSmithKline (GSK) Dermatology Drug Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 GlaxoSmithKline (GSK) Dermatology Drug Product Portfolio
  66. 6.11.5 GlaxoSmithKline (GSK) Recent Developments
  67. 6.12 Allergan
  68. 6.12.1 Allergan Company Information
  69. 6.12.2 Allergan Business Overview
  70. 6.12.3 Allergan Dermatology Drug Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Allergan Dermatology Drug Product Portfolio
  72. 6.12.5 Allergan Recent Developments
  73. 6.13 Almirall S.A.
  74. 6.13.1 Almirall S.A. Company Information
  75. 6.13.2 Almirall S.A. Business Overview
  76. 6.13.3 Almirall S.A. Dermatology Drug Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Almirall S.A. Dermatology Drug Product Portfolio
  78. 6.13.5 Almirall S.A. Recent Developments
  79. 6.14 Amgen
  80. 6.14.1 Amgen Company Information
  81. 6.14.2 Amgen Business Overview
  82. 6.14.3 Amgen Dermatology Drug Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Amgen Dermatology Drug Product Portfolio
  84. 6.14.5 Amgen Recent Developments
  85. 6.15 Astellas
  86. 6.15.1 Astellas Company Information
  87. 6.15.2 Astellas Business Overview
  88. 6.15.3 Astellas Dermatology Drug Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Astellas Dermatology Drug Product Portfolio
  90. 6.15.5 Astellas Recent Developments
  91. 6.16 Concert Pharmaceuticals
  92. 6.16.1 Concert Pharmaceuticals Company Information
  93. 6.16.2 Concert Pharmaceuticals Business Overview
  94. 6.16.3 Concert Pharmaceuticals Dermatology Drug Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Concert Pharmaceuticals Dermatology Drug Product Portfolio
  96. 6.16.5 Concert Pharmaceuticals Recent Developments
  97. 6.17 Eli Lilly and Company
  98. 6.17.1 Eli Lilly and Company Company Information
  99. 6.17.2 Eli Lilly and Company Business Overview
  100. 6.17.3 Eli Lilly and Company Dermatology Drug Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Eli Lilly and Company Dermatology Drug Product Portfolio
  102. 6.17.5 Eli Lilly and Company Recent Developments
  103. 6.18 Lupin
  104. 6.18.1 Lupin Company Information
  105. 6.18.2 Lupin Business Overview
  106. 6.18.3 Lupin Dermatology Drug Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Lupin Dermatology Drug Product Portfolio
  108. 6.18.5 Lupin Recent Developments
  109. 6.19 Mayne Pharma
  110. 6.19.1 Mayne Pharma Company Information
  111. 6.19.2 Mayne Pharma Business Overview
  112. 6.19.3 Mayne Pharma Dermatology Drug Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Mayne Pharma Dermatology Drug Product Portfolio
  114. 6.19.5 Mayne Pharma Recent Developments
  115. 6.20 Merck KGaA
  116. 6.20.1 Merck KGaA Company Information
  117. 6.20.2 Merck KGaA Business Overview
  118. 6.20.3 Merck KGaA Dermatology Drug Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Merck KGaA Dermatology Drug Product Portfolio
  120. 6.20.5 Merck KGaA Recent Developments
  121. 6.21 AstraZeneca plc
  122. 6.21.1 AstraZeneca plc Company Information
  123. 6.21.2 AstraZeneca plc Business Overview
  124. 6.21.3 AstraZeneca plc Dermatology Drug Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 AstraZeneca plc Dermatology Drug Product Portfolio
  126. 6.21.5 AstraZeneca plc Recent Developments
  127. 6.22 Roivant Sciences (Dermavant Sciences)
  128. 6.22.1 Roivant Sciences (Dermavant Sciences) Company Information
  129. 6.22.2 Roivant Sciences (Dermavant Sciences) Business Overview
  130. 6.22.3 Roivant Sciences (Dermavant Sciences) Dermatology Drug Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Roivant Sciences (Dermavant Sciences) Dermatology Drug Product Portfolio
  132. 6.22.5 Roivant Sciences (Dermavant Sciences) Recent Developments
7 North America
  1. 7.1 North America Dermatology Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Dermatology Drug Market Size by Country (2021-2026)
  3. 7.3 North America Dermatology Drug Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Dermatology Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Dermatology Drug Market Size by Country (2021-2026)
  3. 8.3 Europe Dermatology Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Dermatology Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Dermatology Drug Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Dermatology Drug Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Dermatology Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Dermatology Drug Market Size by Country (2021-2026)
  3. 10.3 South America Dermatology Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Dermatology Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Dermatology Drug Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Dermatology Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst